Literature DB >> 17263976

Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.

Yubo Yang1, Hiroaki Nagano, Hideo Ota, Osakuni Morimoto, Masato Nakamura, Hiroshi Wada, Takehiro Noda, Bazarragchaa Damdinsuren, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Keizo Dono, Koji Umeshita, Shoji Nakamori, Kenichi Wakasa, Masato Sakon, Morito Monden.   

Abstract

BACKGROUND: Little is known about the metastatic pattern in patients with extrahepatic metastasis after the removal of primary hepatocellular carcinoma (HCC). The aim of the present study was to determine the clinicopathologic characteristics and prognosis of patients with extrahepatic metastasis from HCC according to the recurrence pattern.
METHODS: Among the patients who underwent hepatic resection for HCC between 1981 and 2001, 80 patients had no recurrence; 221 patients had intrahepatic recurrence, and 47 patients experienced extrahepatic metastasis within a mean follow-up period of 4.8 +/- 3.7 years (+/-SD; range, 2-15 years). The pattern of extrahepatic metastasis after hepatic resection was divided into pattern I (first recurrence in the liver and then spread outside the liver after repetitive intrahepatic recurrences and repetitive locoregional treatments), pattern II (simultaneous recognition of intrahepatic and extrahepatic recurrences), and pattern III (extrahepatic, but no intrahepatic, lesions at first recurrence).
RESULTS: There were significant differences in proportions of patients with invasion of the portal vein, hepatic vein, or inferior vena cava, intrahepatic metastases, and tumor stage between patients with intra- and extrahepatic metastases. The disease-free survival and extrahepatic metastasis-free survival in pattern I were better than pattern II. Survival after extrahepatic metastasis did not correlate with the 3 patterns.
CONCLUSION: Although long-term overall survival was better in patients with pattern I of extrahepatic recurrences, prognosis was poor in all patterns once extrahepatic metastasis developed.

Entities:  

Mesh:

Year:  2007        PMID: 17263976     DOI: 10.1016/j.surg.2006.06.033

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  87 in total

1.  High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection.

Authors:  Xiangjiu Ding; Kexin Wang; Hui Wang; Guangyong Zhang; Yajing Liu; Qingyun Yang; Weijie Chen; Sanyuan Hu
Journal:  J Gastrointest Surg       Date:  2011-11-10       Impact factor: 3.452

2.  Radiological assessment of hepatic vein invasion by hepatocellular carcinoma using combined computed tomography hepatic arteriography and computed tomography arterial portography.

Authors:  Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Kakihara; Daisuke Okamoto; Nobuhiro Fujita; Akinobu Taketomi; Kengo Yoshimitsu; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

3.  A three-dimensional cell biology model of human hepatocellular carcinoma in vitro.

Authors:  Jianhua Tang; Jiefeng Cui; Rongxin Chen; Kun Guo; Xiaonan Kang; Yan Li; Dongmei Gao; Lu Sun; Changde Xu; Jie Chen; Zhaoyou Tang; Yinkun Liu
Journal:  Tumour Biol       Date:  2010-12-08

4.  Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Ming-chun Lai; Zhe Yang; Lin Zhou; Qian-qian Zhu; Hai-yang Xie; Feng Zhang; Li-ming Wu; Lei-ming Chen; Shu-sen Zheng
Journal:  Med Oncol       Date:  2011-06-16       Impact factor: 3.064

Review 5.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

6.  Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.

Authors:  Hajime Aino; Shuji Sumie; Takashi Niizeki; Ryoko Kuromatsu; Nobuyoshi Tajiri; Masahito Nakano; Manabu Satani; Shingo Yamada; Shusuke Okamura; Shigeo Shimose; Hiroaki Sumie; Takuji Torimura; Michio Sata
Journal:  Mol Clin Oncol       Date:  2014-02-14

7.  Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma.

Authors:  Ke Zhang; Li Jiang; Rong He; Bao-Liang Li; Zhe Jia; Rong-Hai Huang; Yi Mu
Journal:  Tumour Biol       Date:  2014-05-07

8.  MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.

Authors:  Shan Lu; Wei Zhou; Haiyun Wei; Leifeng He; Liang Li
Journal:  Dig Dis Sci       Date:  2015-08-18       Impact factor: 3.199

9.  Early effect of hepatic artery TNF-alpha infusion on systemic hemodynamics and inflammation: a dose-response study in pigs.

Authors:  Thilo Schäfer; Jens Sperling; Otto Kollmar; Sven Richter; Martin K Schilling; Michael D Menger; Werner Lindemann
Journal:  Int J Colorectal Dis       Date:  2009-11-04       Impact factor: 2.571

10.  Cytohesin-3 is upregulated in hepatocellular carcinoma and contributes to tumor growth and vascular invasion.

Authors:  Ying Fu; Jun Li; Ming-Xuan Feng; Xiao-Mei Yang; Ya-Hui Wang; Yan-Li Zhang; Wenxin Qin; Qiang Xia; Zhi-Gang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.